(Q33392130)

26 July 2017

title

Effect of genetic alterations of cytarabine- metabolizing enzymes in childhood acute lymphoblastic leukemia (English)

1 reference

26 July 2017

Effect of genetic alterations of cytarabine-metabolizing enzymes in childhood acute lymphoblastic leukemia (English)

1 reference

https://api.crossref.org/works/10.1016/S1658-3876(10)50019-0

25 July 2024

1 reference

lymphoblastic leukemia

1 reference

single-nucleotide polymorphism

inferred from title

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20890066

25 July 2024

5

Suradej Hongeng

1 reference

26 July 2017

7

Samart Pakakasama

1 reference

26 July 2017

Chumphorn Banklau

1

1 reference

26 July 2017

Sumalee Jindadamrongwech

2

1 reference

26 July 2017

Ruchchadol Sawangpanich

3

1 reference

26 July 2017

Suntaree Apibal

4

1 reference

26 July 2017

Karan Paisooksantivatana

6

1 reference

26 July 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20890066

25 July 2024

publication date

1 January 2010

1 reference

full work available at URL

26 July 2017

https://doi.org/10.1016/s1658-3876(10)50019-0

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20890066

https://api.elsevier.com/content/article/PII:S1658387610500190?httpAccept=text/xml

25 July 2024

1 reference

https://api.crossref.org/works/10.1016/S1658-3876(10)50019-0

https://api.elsevier.com/content/article/PII:S1658387610500190?httpAccept=text/plain

25 July 2024

1 reference

https://api.crossref.org/works/10.1016/S1658-3876(10)50019-0

Hematology/oncology and stem cell therapy

25 July 2024

published in

1 reference

26 July 2017

volume

3

1 reference

26 July 2017

issue

3

1 reference

26 July 2017

page(s)

103-108

1 reference

Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2810%2950019-0

7 January 2021

Clinical pharmacokinetics of cytarabine formulations

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2810%2950019-0

7 January 2021

Novel deoxycytidine kinase gene polymorphisms: a population screening study in Caucasian healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2810%2950019-0

7 January 2021

A functional single-nucleotide polymorphism in the human cytidine deaminase gene contributing to ara-C sensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2810%2950019-0

7 January 2021

Association between single nucleotide polymorphisms in deoxycytidine kinase and treatment response among acute myeloid leukaemia patients

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2810%2950019-0

7 January 2021

Gemcitabine pharmacogenomics: cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2810%2950019-0

7 January 2021

Acute lymphoblastic leukemia in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2810%2950019-0

7 January 2021

Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2810%2950019-0

7 January 2021

Ethnic differences of two non-synonymous single nucleotide polymorphisms in CDA gene

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2810%2950019-0

7 January 2021

Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2810%2950019-0

7 January 2021

SNP analyses in cytarabine metabolizing enzymes in AML patients and their impact on treatment response and patient survival: identification of CDA SNP C-451T as an independent prognostic parameter for survival.

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2810%2950019-0

7 January 2021

Predictive value of flow cytometric minimal residual disease analysis in childhood acute lymphoblastic leukaemia at the end of remission induction therapy: results from a single UK centre

1 reference

https://api.crossref.org/works/10.1016%2FS1658-3876%2810%2950019-0

7 January 2021

Status of minimal residual disease testing in childhood haematological malignancies

16

1 reference

https://api.crossref.org/works/10.1016/S1658-3876(10)50019-0

25 July 2024

Identifiers

1 reference

26 July 2017

1 reference